Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07351864 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Study acronym: FIN-SGLT2-HF
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Apr 30, 2026 → Oct 31, 2026
See other at-risk trials from Mansoura University

Record History

  1. Primary completion pushed from Apr 30, 2026 to Oct 31, 2026 Trial status changed: Not Yet Recruiting → Active, Not Recruiting · Completion pushed from Jul 31, 2026 to Oct 31, 2026 · Eligibility criteria expanded, about 9 words · 3 more Show 6 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Completion pushed from Jul 31, 2026 to Oct 31, 2026
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 5 entries
    • Site contact updated
    • Publications: details revised at 3 of 3 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical study is to evaluate whether adding finerenone to standard treatment with a sodium-glucose cotransporter-2 (SGLT2) inhibitor provides additional benefits in patients with heart failure. The main question this study aims to answer is whether the combination of finerenone and an SGLT2 inhibitor improves clinical outcomes and is safe compared to treatment with an SGLT2 inhibitor alone. Participants will receive standard therapy with an SGLT2 inhibitor, with or without the addition of finerenone and will be followed to assess clinical outcomes and safety.
Trial Details
NCT Number NCT07351864
Lead Sponsor Mansoura University
Conditions Heart Failure
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov